AstraZeneca to divest remaining anaesthetics portfolio rights
admin 14th September 2017 Uncategorised 0Rights will be sold to Aspen in $766 million deal
More: AstraZeneca to divest remaining anaesthetics portfolio rights
Source: News
Rights will be sold to Aspen in $766 million deal
More: AstraZeneca to divest remaining anaesthetics portfolio rights
Source: News
© 1994 - 2025 B.M. Pharmaceuticals